BioWorld® - Medical Device Daily

BioWorld Industrial Biotechnology StatReport: Immediate and Comprehensive Industry Information
PRODUCTS ON MARKET: Genotyping services
Pharmacogenetic contract research
Consulting
Eurogentec SA
LIEGE Science Park, Rue Bois Saint Jean 5
Seraing B-4102, Belgium
Phone: +32 4 372 74 00; Fax: +32 4 372 75 00
Web: www.eurogentec.com
E-mail: info@eurogentec.com
KEY PERSONNEL: Joseph Martial, Ph.D.; Chairman
Jean-Pierre Delwart; CEO
Gottfried Proess; Production Manager
Veronique Distexhe; CFO
Daniel Radoux; Sales and Marketing Manager
Philippe Cronet; Biologics Business Unit Director
EMPLOYEES: 290 employees, 33 Ph.D.s
HISTORY: Founded in 1985 as a spin-off of the University of Liege
Began biotech R&D in 1987
Established Nippon EGT joint venture in Japan (8/03)
STOCK-FINANCIAL HISTORY: Privately held
PRIVATE PLACEMENTS: EUR5M private placement (2001)
SUBSIDIARIES/DIVISIONS: Subsidiaries:
Eurogentec France s.a.s.u.
Eurogentec Deutschland GmbH
Eurogentec Nederland b.v.
Eurogentec s.a., succursale de Genève
Nippon EGT Co., Ltd.
RB EGT (Singapore)
Eurogentec North America, Inc.
Eurogentec Ltd.
Biotech-related divisions:
Genomics
Proteomics
Biologics
BUSINESS STRATEGY: Design and deliver reliable and innovative services and products for the life
science community
Act as a leading supplier for genomic and proteomic research, in offering the
company's customers integrated solutions, whether they use DNA,
antibodies, peptides or proteins as research tools
Offer research and development services for the biopharmaceutical industry
AGREEMENTS: Name Products Content of Agreement Date
Alnylam
research products and nonexclusive 7/05
Pharmaceuticals services in RNAi under
Alnylam's Kreutzer-
Limmer patent family
licensing agreement
Copyright ©2006 AHC Media ® 156